Daniel Stauder
Stock Analyst at JMP Securities
(0.44)
# 2431
Out of 5,329 analysts
16
Total ratings
35.71%
Success rate
-2.52%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ATRC AtriCure | Reiterates: Market Outperform | 60 60 | 29.27 | 104.99% | 6 | Apr 30, 2025 | |
STIM Neuronetics | Maintains: Market Outperform | 3 7 | 4.47 | 56.6% | 1 | Mar 5, 2025 | |
LMAT LeMaitre Vascular | Maintains: Strong Buy | 105 110 | 90.36 | 21.74% | 4 | Feb 28, 2025 | |
AXON Axon Enterprise | Reiterates: Market Outperform | 725 725 | 622.05 | 16.55% | 1 | Feb 26, 2025 | |
AORT Artivion | Reiterates: Market Outperform | 33 33 | 23.4 | 41.03% | 3 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | May 7, 2024 |